Immunohistochemical expression of CK20, CK7, and CDX2 in colorectal carcinoma in correlation with pathomorphological characteristics.
| Autor: | Ilieva N; Medical University of Plovdiv, Plovdiv, Bulgaria., Tashkova D; Medical University of Plovdiv, Plovdiv, Bulgaria., Staykov D; Medical University of Plovdiv, Plovdiv, Bulgaria., Serteva D; Medical University of Plovdiv, Plovdiv, Bulgaria., Feodorova Y; Medical University of Plovdiv, Plovdiv, Bulgaria., Mehterov N; Medical University of Plovdiv, Plovdiv, Bulgaria., Mollova A; St George University Hospital, Plovdiv, Bulgaria., Bachurska S; Medical University of Varna, Varna, Bulgaria. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Folia medica [Folia Med (Plovdiv)] 2022 Apr 30; Vol. 64 (2), pp. 214-220. |
| DOI: | 10.3897/folmed.64.e60950 |
| Abstrakt: | Introduction: Colorectal carcinoma is the third most common cancer worldwide. The usual immunophenotype of colorectal adenocarcinoma is CDX2 positive, CK20 positive, and CK7 negative. Aberrant expression is reported in a variety of colorectal carcinomas but its relation to morphological variables and survival data is still unclear. (This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.) |
| Databáze: | MEDLINE |
| Externí odkaz: |
|